𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of gonadotropin-releasing hormone agonists on bone metabolism markers and bone mineral density in patients with prostate cancer

✍ Scribed by Yoshiyuki Miyaji; Takashi Saika; Yasuo Yamamoto; Nobuyuki Kusaka; Ryoji Arata; Shin Ebara; Yasutomo Nasu; Tomoyasu Tsushima; Hiromi Kumon

Book ID
116944240
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
107 KB
Volume
64
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Changes in bone mineral density and body
Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinoma
✍ Hang Lee; Katelyn McGovern; Joel S. Finkelstein; Matthew R. Smith πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Initial treatment with a gonadotropin‐releasing hormone (GnRH) agonist increases fat mass, decreases lean body mass, and decreases bone mineral density (BMD) in men with prostate carcinoma. To the authors' knowledge, little is known regarding either the long‐term effects